Bulletin
Investor Alert

Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 1, 2022, 7:59 p.m.

/zigman2/quotes/205619834/composite

$

149.95

Change

0.00 0.00%

Volume

Volume 74,163

Quotes are delayed by 20 min

/zigman2/quotes/205619834/composite

Previous close

$ 142.85

$ 149.95

Change

+7.10 +4.97%

Day low

Day high

$139.54

$151.10

Open

52 week low

52 week high

$115.61

$497.49

Open

Annual Financials for Moderna Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 205.83M135.07M60.21M803.4M18.41B
Cost of Goods Sold (COGS) incl. D&A 20.54M24.86M31.02M39.18M2.85B
COGS excluding D&A ---7.93M2.62B
Depreciation & Amortization Expense 20.54M24.86M31.02M31.25M232M
Depreciation 20.54M24.86M31.02M31.25M232M
Amortization of Intangibles -----
Gross Income 185.29M110.21M29.19M764.21M15.56B
20172018201920202021 5-year trend
SG&A Expense 454.64M579.07M574.91M1.53B2.33B
Research & Development 410.46M509.68M465.29M1.34B1.76B
Other SG&A 44.19M69.39M109.62M188.27M-
Other Operating Expense -----
Unusual Expense ---1.6M-
EBIT after Unusual Expense ---(764.74M)-
Non Operating Income/Expense (1.74M)4.93M(914,000)5.4M47M
Non-Operating Interest Income 15.24M27.02M38.53M24.72M18M
Equity in Affiliates (Pretax) -----
Interest Expense 132,0003.1M6.61M9.89M18M
Gross Interest Expense 132,0003.1M6.61M9.89M18M
Interest Capitalized -----
Pretax Income (256M)(440.01M)(514.72M)(744.51M)13.29B
Income Tax (80,000)(55.27M)(695,000)2.55M1.08B
Income Tax - Current Domestic (80,000)326,000505,00032,0001.34B
Income Tax - Current Foreign ---2.52M40M
Income Tax - Deferred Domestic --(1.2M)-(294M)
Income Tax - Deferred Foreign ----(2M)
Income Tax Credits -55.6M---
Equity in Affiliates -----
Other After Tax Income (Expense) -(4.13M)---
Consolidated Net Income (255.92M)(388.86M)(514.02M)(747.06M)12.2B
Minority Interest Expense -----
Net Income (255.92M)(388.86M)(514.02M)(747.06M)12.2B
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (255.92M)(388.86M)(514.02M)(747.06M)12.2B
Preferred Dividends 13.93M13M---
Net Income Available to Common (269.84M)(401.86M)(514.02M)(747.06M)12.2B
EPS (Basic) (1.92)(4.95)(1.55)(1.96)30.28
Basic Shares Outstanding 140.6M81.11M330.8M381.33M403M
EPS (Diluted) (1.92)(4.95)(1.55)(1.96)28.31
Diluted Shares Outstanding 140.6M81.11M330.8M381.33M431M
EBITDA (248.82M)(444M)(514.7M)(731.89M)13.47B
Link to MarketWatch's Slice.